Antimicrobial Resistance

Debate between Lord Collins of Highbury and Lord Patel

Tuesday 23rd July 2024 Lords Chamber

[Lord Collins of Highbury (Lab)]

I do not think the things are necessarily linked; the noble Lord knows our commitment to 0.7%, and we want to return to it as soon as the fiscal situation allows. In the meantime, we want to focus on the impact of our ODA, and that is why this political declaration is so important, because we can achieve a lot. One of the things we will be doing is looking at the plans and commitments that the previous Government made, and ensure that we work in partnership with African countries to deliver the biggest impact.

[Lord Patel (CB)]

My Lords, while accepting that we need to do everything possible to control the increasing incidence of antibiotic resistance, would the Minister agree that we should also pursue research that would find other forms of treatment to control bacterial infections? For instance, there are new antibiotics such as the one developed in Harvard University that changes the way it works on bacterial infections or, secondly, the one developed in Imperial College London, which has been developed to disrupt the microbiology of bacteria. Thirdly and importantly is developing viruses that act as bacteriophages to destroy the bacterial infections, but that requires a manufacturing facility; in January, the Science, Innovation and Technology Select Committee recommended that we should develop one in the old Rosalind Franklin Laboratory in the north. Would the Minister comment?

[Lord Collins of Highbury (Lab)]

I was extremely grateful for the noble Lord catching me in the corridor just before, warning me about this. The noble Baroness, Lady Bennett, emphasised the importance of research, and it is constantly developing. We must look at it not only in terms of the problems we face in this country but also the issues faced in low to middle-income countries. The noble Lord is absolutely right, and our first commitment out of the high-level panel meeting is to focus on the need for greater research. But I accept what the noble Lord says: we are a centre of excellent research in this country, and we need to make sure that the benefits of that research are reflected in our ability to turn research into those manufacturing capabilities. I am very pleased that my honourable friend in DSIT will be absolutely focused on ensuring that is the case.